
    
      The patients with solitary tumor more than 5cm and microvessels invasion after radical
      hepatectomy were randomized to receive adjuvant FOLFOX chemotherapy ï¼ˆ8~12 cycles) or
      follow-up. The main endpoint: overall survival (OS), disease-free survival(DFS) and safety
      were compared between this two groups.
    
  